Care and treatment guided by structural psychosocial screening leads to a better quality of life and greater patient satisfaction than usual care in patients with lung cancer. The second goal is to relate the change in quality of life with theā¦
ID
Bron
Verkorte titel
Aandoening
Lungcancer, psychosocial signaling, Distress Thermometer and Problem list, psychosocial oncology, casemanagement, quality of life.
Longkanker, psychosociale signalering, lastmeter, psychosociale oncologie, casemanagement, kwaliteit van leven.
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Quality of life (QOL) as measured by the EORTC-QLQ-30 questionnaire and its lung module QLQ-LC13, the Hospital anxiety and depression scale and the EuroQol 5 EQ-5D.
Achtergrond van het onderzoek
The aim is to examine, whether care and treatment guided by structural psychosocial screening, leads to a better quality of life and increased patient satisfaction than usual care in patients with lung cancer. Psychosocial screening consists of regular and structural screening of problems using the Dutch Distress Thermometer and Problem (DTP) list, communication with the patient regarding the response pattern, and referral to a psychosocial or paramedic care giver when indicated or desired by the patient. Eligible are all patients visiting the UMCG department of lung oncology with a recently confirmed diagnosis of lung cancer or recently documented recurrence. The study has a randomized parallel design. Patients will be randomly assigned to either standard care or to the experimental group. Patients in the experimental group will receive care guided by repeated structural psychosocial screening with the DTP list on top of usual care.
Primary outcome parameter is: Quality of life; secondary outcomes are: patient satisfaction with care, total costs both inside and outside the hospital, cost effectiveness, progression free and overall survival.
Doel van het onderzoek
Care and treatment guided by structural psychosocial screening leads to a better quality of life and greater patient satisfaction than usual care in patients with lung cancer.
The second goal is to relate the change in quality of life with the total costs incurred both inside and outside the hospital.
Onderzoeksopzet
Participants will be asked to complete questionnaires after inclusion, when they have started with chemotherapie. Again at 7 (T2), 13 (T3) and 25 weeks (T4) later.
All questionnaires will be sent to (surviving) participants again at one and two years after completion of the study to examine long-term effects.
Onderzoeksproduct en/of interventie
Patients in the standard care group will receive the usual care and attention of the health care professionals as dictated by the institute.
Patients in the experimental group will receive extra psychosocial care delivered by an oncology nurse on top of the standard care. This extra care consists of, care guided by structural psychosocial screening with a screening instrument (the Dutch version of the distress thermometer and problem [DTP] list). These patients will complete the DTP list within 3 weeks, and at 7, 13 and 25 weeks after inclusion. The DTP lists will be sent to the patient 1 week prior to the outpatient clinic visit. The oncology nurse will act as case manager for patients in the experimental group. At each of the visits, the oncology nurse will discuss the response pattern from the DTP list with the patient. When needed, she will refer the patient to a psychosocial health care provider. In addition, when indicated, responses will also be discussed in the multidisciplinary psychosocial team.
Publiek
H.A.M. Kerstjens
Groningen 9700 RB
The Netherlands
+31 (0)50 3612357
h.a.m.kerstjens@int.umcg.nl
Wetenschappelijk
H.A.M. Kerstjens
Groningen 9700 RB
The Netherlands
+31 (0)50 3612357
h.a.m.kerstjens@int.umcg.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Starting a treatment with chemotherapy for either recently confirmed diagnosis of lung cancer, documented recurrence of lung cancer, thymoma or mesothelioma;
2. Disease stage Ib - IV;
3. ECOG Performance score 0-2;
4. Age > 18 years.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Actual psychiatric disorder.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL3398 |
NTR-old | NTR3540 |
Ander register | METc : 2009/346 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |